Nael Abdelsamad MD, MBA , FACHE
Physician–executive with over a decade of cross-sector leadership in healthcare, academia, and industry. As Head of Research at Cleveland Clinic Abu Dhabi, I lead the transformation of the institution’s research enterprise, expanding its portfolio to more complex, interventional, and early-phase trials, including first-in-human studies such as Neuralink's landmark UAE PRIME trial. Under my leadership, the institution has grown into a regional center of excellence for complex, interventional, and early-phase clinical trials.
Previously, I served as the Medical Director at CVS Health’s Clinical Trial Services, where I oversaw national recruitment operations for 40+ multicenter BioPharma trials and implemented data-driven strategies that significantly improved enrollment performance and operational efficiency.
My work focuses on building research ecosystems that advance clinical discovery, integrate AI and data science, and bridge the gap between innovation and patient impact. Through collaborations with leading AI organizations such as G42 and MBZUAI, I’m helping shape the UAE’s role as a global hub for life sciences and tech-enabled healthcare.
Certifications
Certified Principal Investigator (CPI®)
Certified Clinical Research Coordinator (CCRC®)
Fellow of the American College of Healthcare Executives
Lean Six Sigma Certified
Board Memberships
MBL Health
MBZUAI & CCAD AI in Research Steering Committee
Research Ethics Committee Cleveland Clinic Abu Dhabi
Association of Clinical Research Professionals CPI Exam Committee
Education
M.D. Weill Cornell Medicine
M.B.A. Healthcare Managment, Western Governors University


Select Publications
Mechanisms to expedite pediatric clinical trial site activation, The DOSE trial Experience
Contemporary Clinical Trials (2023)
Using single IRB consultations to meet the educational needs of investigative teams
Contemporary Clinical Trials Communications (2022)
Development of a risk assessment and risk management tool for an academic research organization
Contemporary Clinical Trials Communications (2022)
Diabetic muscle infarction: often misdiagnosed and mismanaged
Diabetes, Metabolic Syndrome Targets and Therapy (2019)
Let’s Map Your Next Phase of Growth.
We’ll assess your objectives, identify structural gaps, and define a clear path forward across U.S. and UAE ecosystems.
Let’s Talk Strategy.
Advisory@ClincalNexus.net
© 2026 All rights reserved.
Be Informed.
Strategic insights on clinical research and market entry in the UAE
